These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18393881)

  • 21. The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes.
    Del Rosso JQ; Kircik LH; Zeichner J; Stein Gold L
    J Drugs Dermatol; 2019 Feb; 18(2s):s100-s107. PubMed ID: 30811153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
    Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
    Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basics of topical therapy].
    Wohlrab J
    Hautarzt; 2014 Mar; 65(3):169-74. PubMed ID: 24424729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
    Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
    Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcipotriol delivery into the skin with PEGylated liposomes.
    Knudsen NØ; Rønholt S; Salte RD; Jorgensen L; Thormann T; Basse LH; Hansen J; Frokjaer S; Foged C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):532-9. PubMed ID: 22538098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodrugs and soft drugs.
    Stańczak A; Ferra A
    Pharmacol Rep; 2006; 58(5):599-613. PubMed ID: 17085852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs.
    Sengupta P; Chatterjee B
    Int J Pharm; 2017 Jun; 526(1-2):353-365. PubMed ID: 28461261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
    Wang Y; Xu X; Gu Y; Cheng Y; Cao F
    Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of various topical ophthalmic delivery systems.
    Frangie JP
    Clin Pharmacokinet; 1995 Aug; 29(2):130-8. PubMed ID: 7586901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles and approaches for optimizing therapy with unique topical vehicles.
    Rosen J; Landriscina A; Friedman AJ
    J Drugs Dermatol; 2014 Dec; 13(12):1431-5. PubMed ID: 25607783
    [No Abstract]   [Full Text] [Related]  

  • 35. Galenical principles in skin protection.
    Zhang J; Smith EW; Surber C
    Curr Probl Dermatol; 2007; 34():11-18. PubMed ID: 17312353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum].
    Sugino M; Todo H; Sugibayashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1453-8. PubMed ID: 19952520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carriers in the topical treatment of skin disease.
    Korting HC; Schäfer-Korting M
    Handb Exp Pharmacol; 2010; (197):435-68. PubMed ID: 20217539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe and effective application of topical treatments to the skin.
    Lawton S
    Nurs Stand; 2013 Jun 19-25; 27(42):49-56; quiz 58, 60. PubMed ID: 23930532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous penetration of anticancer agents: Past, present and future.
    Ita K
    Biomed Pharmacother; 2016 Dec; 84():1428-1439. PubMed ID: 27802901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.